Search

Osteosarcoma is the most common primary bone sarcoma that mostly occurs in young adults. The causes of osteosarcoma are heterogeneous and still not fully understood. Identification of novel, important oncogenic factors in osteosarcoma and development of better, effective therapeutic approaches are in urgent need for better treatment of osteosarcoma patients. In this study, we uncovered that the oncogene MYC is significantly upregulated in metastastic osteosarcoma samples. In addition, high MYC expression is associated with poor survival of osteosarcoma patients. Analysis of MYC targets in osteosarcoma revealed that most of the osteosarcoma super enhancer genes are bound by MYC. Treatment of osteosarcoma cells with super enhancer inhibitors THZ1 and JQ1 effectively suppresses the proliferation, migration, and invasion of osteosarcoma cells. Mechanistically, THZ1 treatment suppresses a large group of super enhancer containing MYC target genes including CDK6 and TGFB2. These findings revealed that the MYC-driven super enhancer signaling is crucial for the osteosarcoma tumorigenesis and targeting the MYC/super enhancer axis represents as a promising therapeutic strategy for treatment of osteosarcoma patients. Insight into a molecular pathway involved in an aggressive bone cancer has suggested a new approach to its treatment. Osteosarcoma usually develops in growing bone tissue, but often spreads to other organs, consequently reducing survival. The molecular mechanisms behind osteosarcoma are not fully understood. A team led by Shuibin Lin from Sun Yat-sen University investigated the role of MYC, a gene that is important in other cancers. They found that increased expression of MYCis associated with the spread of osteosarcoma and a poor prognosis because the protein product of MYCactivates many super-enhancers, regions of DNA that increase the expression of cancer-related genes. Inhibition of the super-enhancers suppressed growth and spreading of osteosarcoma in cultured cells and a mouse model, suggesting a novel therapeutic approach to osteosarcoma.

In this paper, the flexural wave propagation and localization in randomly disordered binary periodic beams with the axial load are studied. Based on the continuity conditions, the transfer matrix between the constitutive unit cells is derived. The expression of the localization length in the disordered periodic system is presented. Numerical calculations are performed to illustrate the localization characteristics of the flexural wave. The effects of the axial load on the band gap structures and the localization properties are discussed. From the results, we can observe that the properties of the pass band and stop band for the perfect system can be tuned by the axial load. Moreover, the localization properties of the flexural wave will be strengthened by the higher disordered degree.

Phononic crystals (PCs) and metamaterials (MMs) can exhibit abnormal properties, even far beyond those found in nature, through artificial design of the topology or ordered structure of unit cells. This emerging class of materials has diverse application potentials in many fields. Recently, the concept of tunable PCs or MMs has been proposed to manipulate a variety of wave functions on demand. In this review, we survey recent developments in tunable and active PCs and MMs, including bandgap and bandgap engineering, anomalous behaviors of wave propagation, as well as tunable manipulation of waves based on different regulation mechanisms: tunable mechanical reconfiguration and materials with multifield coupling. We conclude by outlining future directions in the emerging field.